In terms of valuation, Mira Pharmaceuticals Inc’s market capitalization stands at $15.52 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...

"We are fully committed to bringing this breakthrough drug to patients as quickly as possible while backing everything we do ...

Bayer on Tuesday said it had applied for marketing authorization with the European Medicines Agency (EMA) for its menopause ...

It was unclear what role Bubeck would assume at the Microsoft-backed AI startup. "Sebastian has decided to leave Microsoft to ...

Welcome to Edition 7.15 of the Rocket Report! It's a big week for big rockets, with SpaceX potentially launching its next ...

This prediction is currently active. Massive losses of -67.63% have been the result for the SELL prediction by Lokrim. This prediction currently runs until 23.07.25. The prediction end date can be ...

Erez Aminov, CEO & Chairman of the Board, and Dr. Itzchak Angel, Chief Scientific Advisor for MIRA Pharmaceuticals MIRA, were recently interviewed by Benzinga. MIRA is a pre-clinical biopharma ...

Fintel reports that on September 30, 2024, Rodman & Renshaw initiated coverage of MIRA Pharmaceuticals (NasdaqCM:MIRA) with a ...

On Monday, Mira Pharmaceuticals Inc (MIRA) stock saw a modest uptick, ending the day at $1.3 which represents a slight increase of $0.14 or 12.07% from the prior close of $1.16. The stock opened at $1 ...